The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
Mar. 18, 2021
Applicant:
Athanor Biosciences, Inc., Halethorpe, MD (US);
Inventors:
Hossein A Ghanbari, Potomac, MD (US);
Michael S. Lebowitz, Pikesville, MD (US);
Assignee:
Athanor Biosciences, Inc., Halethorpe, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 7/00 (2006.01); C12N 7/01 (2006.01); A61K 35/76 (2015.01); A61K 39/215 (2006.01); A61K 39/295 (2006.01); C07K 14/005 (2006.01); C12N 15/87 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/295 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/87 (2013.01); A61K 2039/70 (2013.01); C12N 2795/00034 (2013.01);
Abstract
Engineered bacteriophage and methods of forming the bacteriophage are described. Multivalent bacteriophage are described that can include multiple different exogenous polypeptides at a surface of the capsid head. Vaccines and methods of forming and using vaccines are described. A vaccine can include an engineered bacteriophage that exhibits an immunogenic exogenous polypeptide at a surface of the bacteriophage. Multivalent bacteriophage and immunogenic bacteriophage are free of nucleic acids encoding the exogenous polypeptide(s).